or
forgot password

    • cancer clinical trials in durham, NC

    • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Melanoma (Skin)
    Nutrition Intervention in Treating Women With Breast Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer
    Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
    Duke Univ. Med. Ctr. Adult CRS
    Durham, North Carolina 27710
    HIV Infections, Sexually Transmitted Diseases
    Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Melanoma (Skin)
    Surgery in Treating Patients With Prostate Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Sarcoma
    Hormone Therapy in Treating Patients With Prostate Cancer
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Prostate Cancer, Sexual Dysfunction and Infertility
    Immunotherapy in Treating Patients With Metastatic Breast Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia
    Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Leukemia
    Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    VX-710, Doxorubicin, and Vincristine in Treating Patients With Recurrent Small Cell Lung Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Lung Cancer
    Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Durham Regional Hospital
    Breast Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Veno-Occlusive Disease
    Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Leukemia
    Paclitaxel in Treating Patients With Ovarian Stromal Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Ovarian Cancer
    Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Endometrial Cancer
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Regional Hematology Oncology Associates
    Durham, North Carolina 27704
    Colorectal Cancer
    Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Breast Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease
    Duke University
    Durham, North Carolina 27710
    Graft-vs-Host Disease
    Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia, Lymphoma
    EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    Duke Comprehensive Cancer Center

    Trial Locations
    Duke Comprehensive Cancer Center
    Veterans Affairs Medical Center - Durham
    Lung Cancer
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    Duke University Medical Center
    Durham, North Carolina 27710
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Lung Cancer
    GW786034 in Treating Patients With Advanced Solid Tumors
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Endometrial Cancer
    Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
    Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
    Duke University Medical Center
    Durham, North Carolina 27710
    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
    Stem Cell Transplantation in Individuals With Multiple Myeloma
    Duke University Medical Center
    Durham, North Carolina 27710
    Multiple Myeloma
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Duke University Medical Center
    Durham, North Carolina 27710
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Brain and Central Nervous System Tumors
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Kidney Cancer
    Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer